Rivaroxaban for a Patient with Class III Obesity: Case Report with Literature Review.

Autor: Bates D; BScPharm, ACPR, is a Clinical Pharmacist, Internal Medicine with the Peter Lougheed Center, Alberta Health Services, Calgary Zone, Calgary, Alberta., Edwards J; BScPharm, ACPR, is a Clinical Pharmacist, Internal Medicine with the Peter Lougheed Center, Alberta Health Services, Calgary Zone, Calgary, Alberta., Shrum J; MD, is a Clinical Lecturer with the Cumming School of Medicine, University of Calgary, Calgary, Alberta., Chan C; MD, is an Internal Medicine Resident with the University of Calgary, Calgary, Alberta., Manga S; is a medical student with the University of Calgary, Calgary, Alberta., MacKay E; MD, MPH, is a Clinical Associate Professor with the Cumming School of Medicine, University of Calgary, Calgary, Alberta.
Jazyk: angličtina
Zdroj: The Canadian journal of hospital pharmacy [Can J Hosp Pharm] 2018 Jan-Feb; Vol. 71 (1), pp. 36-43. Date of Electronic Publication: 2018 Mar 07.
Abstrakt: Competing Interests: Competing interests: None declared.
Databáze: MEDLINE